|
US8090120B2
(en)
|
2004-10-26 |
2012-01-03 |
Dolby Laboratories Licensing Corporation |
Calculating and adjusting the perceived loudness and/or the perceived spectral balance of an audio signal
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
US20110092554A1
(en)
*
|
2007-11-19 |
2011-04-21 |
Richard Chesworth |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
NZ595035A
(en)
|
2007-11-27 |
2012-11-30 |
Ardea Biosciences Inc |
Substituted diazole and triazole compounds and compositions and methods of use
|
|
KR20100135711A
(ko)
|
2007-12-20 |
2010-12-27 |
엔비보 파마슈티칼즈, 인코퍼레이티드 |
사중치환된 벤젠
|
|
US8242154B2
(en)
|
2008-09-04 |
2012-08-14 |
Ardea Biosciences, Inc. |
Compounds, compositions and methods of using same for modulating uric acid levels
|
|
US9340569B2
(en)
*
|
2008-11-03 |
2016-05-17 |
Tufts University |
Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
|
|
EP2255813A1
(en)
*
|
2009-05-29 |
2010-12-01 |
The Royal College of Surgeons in Ireland |
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
|
|
MX2012007759A
(es)
|
2009-12-29 |
2012-08-01 |
Mapi Pharma Ltd |
Compuestos intermedios y procesos para la preparacion de tapentadol y compuestos relacionados.
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
MX342288B
(es)
|
2010-04-22 |
2016-09-23 |
Vertex Pharma |
Proceso para producir compuestos de cicloalquilcarboxamido-indol.
|
|
AR081930A1
(es)
|
2010-06-16 |
2012-10-31 |
Ardea Biosciences Inc |
Compuestos de tioacetato
|
|
WO2011159840A2
(en)
|
2010-06-16 |
2011-12-22 |
Ardea Biosciences, Inc. |
Phenylthioacetate compounds, compositions and methods of use
|
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2776028B1
(en)
|
2011-11-03 |
2018-10-17 |
Ardea Biosciences, Inc. |
3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
|
|
EP2844257A4
(en)
|
2012-05-01 |
2016-06-01 |
Catabasis Pharmaceuticals Inc |
Fatty Acid Conjugates from Statin and FXR Agonists; COMPOSITIONS AND METHODS OF USE
|
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
|
CN104822374A
(zh)
|
2012-09-27 |
2015-08-05 |
儿童医学中心公司 |
用于治疗肥胖症的化合物和其使用方法
|
|
US9475749B2
(en)
|
2013-03-14 |
2016-10-25 |
University Of Macau |
Anti-neurodegenerative natural compound isolated from alpiniae oxyphyllae fructose and their total synthesis
|
|
KR102447581B1
(ko)
|
2014-04-15 |
2022-09-28 |
버텍스 파마슈티칼스 인코포레이티드 |
낭포성 섬유증 막전도 조절자 매개 질환 치료용 약제학적 조성물
|
|
CA2966885A1
(en)
*
|
2014-11-06 |
2016-05-12 |
Enanta Pharmaceuticals, Inc. |
Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
KR20170099909A
(ko)
|
2014-11-26 |
2017-09-01 |
이난타 파마슈티칼스, 인코포레이티드 |
Fxr/tgr5 작용제로서의 담즙산 유사체 및 이의 이용 방법
|
|
US11578097B2
(en)
|
2014-11-26 |
2023-02-14 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
|
|
HK1245100A1
(zh)
|
2015-02-11 |
2018-08-24 |
Enanta Pharmaceuticals, Inc. |
作为fxr/tgr5激动剂的胆汁酸类似物及其使用方法
|
|
NZ735126A
(en)
|
2015-03-31 |
2022-10-28 |
Enanta Pharm Inc |
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
US10323060B2
(en)
|
2016-02-23 |
2019-06-18 |
Enanta Pharmaceuticals, Inc. |
Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
|
|
WO2017147159A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
US10323061B2
(en)
|
2016-02-23 |
2019-06-18 |
Enanta Pharmaceuticals, Inc. |
Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof
|
|
DE102017005884A1
(de)
|
2016-07-07 |
2018-01-11 |
Merck Patent Gmbh |
Elektronisches Schaltelement
|
|
AU2017368069B2
(en)
|
2016-11-29 |
2021-07-08 |
Enanta Pharmaceuticals, Inc. |
Process for preparation of sulfonylurea bile acid derivatives
|
|
WO2018152171A1
(en)
|
2017-02-14 |
2018-08-23 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as fxr agonists and methods of use thereof
|
|
JP7136802B2
(ja)
|
2017-04-07 |
2022-09-13 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
スルホニルカルバマート胆汁酸誘導体の調製のためのプロセス
|
|
DE102018004733A1
(de)
*
|
2018-06-14 |
2019-12-19 |
Merck Patent Gmbh |
Verfahren zur Herstellung eines elektronischen Bauteils enthaltend eine selbstorganisierte Monolage
|
|
CN116925168A
(zh)
*
|
2019-08-23 |
2023-10-24 |
深圳云合医药科技合伙企业(有限合伙) |
胆汁酸衍生物及其组合物和应用
|
|
JP2024529444A
(ja)
*
|
2021-07-26 |
2024-08-06 |
シャペロン インク． |
ＴＮＦ－α生成及び炎症複合体活性抑制新規化合物及びその製造方法
|